Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascendis, Avidity, Everest, In8bio, Merck, Metsera, Newamsterdam, Polypid, Regeneron, Sanofi, Vertex.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Ascentage, Duality, Immuneoncia, Innovent, Kura, Nasus, Otsuka, Remegen, Teva.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Corcept, Duality, Immunic, Maia, Novartis, Regenxbio.